Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 2007, 57: 43-66. 10.3322/canjclin.57.1.43.
Article
PubMed
Google Scholar
Gleason DF, The Veterans Administration Cooperative Research Group: Histologic Grading and Clinical Staging of Prostate Cancer. Urologic Pathology: The Prostate. Edited by: Tannenbaum M. 1977, Philadelphia: Lea & Febiger, 171-174.
Google Scholar
Partin AW, Yoo J, Carter HB, Pearson JD, Chan DW, Epstein JI, Walsh PC: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer [see comments]. Journal of Urology. 1993, 150: 110-114.
CAS
PubMed
Google Scholar
Partin AW, Kattan MW, Subong EN, Walsh PC, Wojno KJ, Oesterling JE, Scardino PT, Pearson JD: Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update [see comments] [published erratum appears in JAMA 1997 Jul 9;278(2):118]. Jama. 1997, 277: 1445-1451. 10.1001/jama.277.18.1445.
Article
CAS
PubMed
Google Scholar
Kattan MW, Eastham JA, Stapleton AM, Wheeler TM, Scardino PT: A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. Journal of the National Cancer Institute. 1998, 90: 766-771. 10.1093/jnci/90.10.766.
Article
CAS
PubMed
Google Scholar
Kattan MW, Eastham JA, Stapleton AMF, Wheeler TM, Scardino PT: A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer. Journal of the National Cancer Institute. 1998, 90: 766-771. 10.1093/jnci/90.10.766.
Article
CAS
PubMed
Google Scholar
D'Amico A, Whittington R, Malkowicz S, Fondurulia J, Chen M, Kaplan I, Beard C, Tomaszewski J, Renshaw A, Wein A, Coleman C: Pretreatment Nomogram for Prostate-Specific Antigen Recurrence After Radical Prostatectomy or External-Beam Radiation Therapy for Clinically Localized Prostate Cancer. Journal of Clinical Oncology. 1999, 17: 168-172.
PubMed
Google Scholar
Healy DG: Case-control studies in the genomic era: a clinician's guide. Lancet Neurol. 2006, 5: 701-707. 10.1016/S1474-4422(06)70524-5.
Article
CAS
PubMed
Google Scholar
Witte JS, Goddard KA, Conti DV, Elston RC, Lin J, Suarez BK, Broman KW, Burmester JK, Weber JL, Catalona WJ: Genomewide scan for prostate cancer-aggressiveness loci. Am J Hum Genet. 2000, 67: 92-99. 10.1086/302960.
Article
CAS
PubMed
PubMed Central
Google Scholar
Huang H, Reed CP, Zhang JS, Shridhar V, Wang L, Smith DI: Carboxypeptidase A3 (CPA3): a novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells. Cancer Res. 1999, 59: 2981-2988.
CAS
PubMed
Google Scholar
Rehli M, Krause SW, Kreutz M, Andreesen R: Carboxypeptidase M is identical to the MAX.1 antigen and its expression is associated with monocyte to macrophage differentiation. J Biol Chem. 1995, 270: 15644-15649. 10.1074/jbc.270.26.15644.
Article
CAS
PubMed
Google Scholar
Kayashima T, Yamasaki K, Yamada T, Sakai H, Miwa N, Ohta T, Yoshiura K, Matsumoto N, Nakane Y, Kanetake H, Ishino F, Niikawa N, Kishino T: The novel imprinted carboxypeptidase A4 gene (CPA4) in the 7q32 imprinting domain. Hum Genet. 2003, 112: 220-226.
CAS
PubMed
Google Scholar
Pallares I, Bonet R, Garcia-Castellanos R, Ventura S, Aviles FX, Vendrell J, Gomis-Ruth FX: Structure of human carboxypeptidase A4 with its endogenous protein inhibitor, latexin. Proc Natl Acad Sci USA. 2005, 102: 3978-3983. 10.1073/pnas.0500678102.
Article
CAS
PubMed
PubMed Central
Google Scholar
D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. Jama. 1998, 280: 969-974. 10.1001/jama.280.11.969.
Article
PubMed
Google Scholar
Liu X, Plummer SJ, Nock NL, Casey G, Witte JS: Nonsteroidal antiinflammatory drugs and decreased risk of advanced prostate cancer: modification by lymphotoxin alpha. Am J Epidemiol. 2006, 164: 984-989. 10.1093/aje/kwj294.
Article
PubMed
Google Scholar
Samid D, Hudgins WR, Shack S, Liu L, Prasanna P, Myers CE: Phenylacetate and phenylbutyrate as novel, nontoxic differentiation inducers. Adv Exp Med Biol. 1997, 400A: 501-505.
Article
CAS
PubMed
Google Scholar
Dashwood RH, Ho E: Dietary histone deacetylase inhibitors: From cells to mice to man. Semin Cancer Biol. 2007
Google Scholar
Johnstone RW: Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat Rev Drug Discov. 2002, 1: 287-299. 10.1038/nrd772.
Article
CAS
PubMed
Google Scholar